These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8683994)

  • 1. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2.
    Hedley DW; McCulloch EA
    Leukemia; 1996 Jul; 10(7):1143-9. PubMed ID: 8683994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An oxidative stress-mediated death pathway in irradiated human leukemia cells mapped using multilaser flow cytometry.
    Sheng-Tanner X; Bump EA; Hedley DW
    Radiat Res; 1998 Dec; 150(6):636-47. PubMed ID: 9840183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
    Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
    Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
    Yang GS; Minden MD; McCulloch EA
    Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
    Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
    J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between the mitochondrial permeability transition and oxidative stress during ara-C toxicity.
    Backway KL; McCulloch EA; Chow S; Hedley DW
    Cancer Res; 1997 Jun; 57(12):2446-51. PubMed ID: 9192824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity.
    Yang GS; Wang C; Minden MD; McCulloch EA
    Leukemia; 1994 Dec; 8(12):2052-9. PubMed ID: 7807994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
    Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
    Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1995 Oct; 9(10):1667-73. PubMed ID: 7564507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
    Bullock G; Ray S; Reed JC; Krajewski S; Ibrado AM; Huang Y; Bhalla K
    Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
    Koistinen P; Wang C; Curtis JE; McCulloch EA
    Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C.
    Keith FJ; Bradbury DA; Zhu YM; Russell NH
    Leukemia; 1995 Jan; 9(1):131-8. PubMed ID: 7845007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular redox state and its relationship to the inhibition of clonal cell growth and the induction of apoptosis during all-trans retinoic acid exposure in acute myeloblastic leukemia cells.
    Mäntymaa P; Guttorm T; Siitonen T; Säily M; Savolainen ER; Levonen AL; Kinnula V; Koistinen P
    Haematologica; 2000 Mar; 85(3):238-45. PubMed ID: 10702810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA; Groshek P; Griffin JD
    Leukemia; 1989 May; 3(5):328-34. PubMed ID: 2654494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.